Sirius XM, Dell, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday

Alumis New Phase 3 ONWARD Data Show Envudeucitinib Improved Scalp, Itch And Quality Of Life In Psoriasis, Building On 54% PASI 100 At Week 48; NDA On Track For 4Q 2026

– Results build on ONWARD3 highest complete skin clearance (54% PASI 100) at Week 48, reinforcing envudeucitinib’s potential to become a leading oral therapy for moderate-to-severe plaque psoriasis– Patients switching

Shares of space-related companies are trading lower, possibly as Rocket Lab extended losses, falling over 8% after an analyst cut its price target following a delay to its Neutron rocket’s first launch, weighing on peers.

Why Is AST SpaceMobile Stock Falling Friday?

ASTS stock hits technical lows following a analyst downgrade from Piper Sandler, driven by satellite launch delays and SpaceX competition.

Space Stock Watch: SpaceX Spectrum Deal, Rocket Lab Delays, Tesla Merger Chatter

Space stocks fall as SpaceX pursued an $8B wireless push, Rocket Lab delays Neutron to 2027, and Tesla’s Roadster revives merger speculation.

Peter Schiff Warns Trump’s ‘Booming’ Stock Market Boast Is a Mirage: 479 Stocks Hit 52-Week Lows on Wednesday, While Only 60 Set Highs

Investor Peter Schiff challenged Trump’s booming stock market claim, pointing to a wave of stocks hitting 52-week lows Wednesday.

BTIG Maintains Buy on AtriCure, Raises Price Target to $63

BTIG analyst Ryan Zimmerman maintains AtriCure (NASDAQ:ATRC) with a Buy and raises the price target from $55 to $63.